H.Jerome Crampton

Efficacy and tolerability of ophthalmic epinastine assessed using the conjunctival antigen challenge model in patients with a history of allergic conjunctivitis

Mark B. Abelson, Paul J Gomes, H.Jerome Crampton et al. · Clinical Therapeutics · 2004 · 59 citations

Medicine, Immunology, Ophthalmology +15

Comparison of ketotifen fumarate ophthalmic solution alone, desloratadine alone, and their combination for inhibition of the signs and symptoms of seasonal allergic rhinoconjunctivitis in the conjunctival allergen challenge model: a double-masked, placebo- and active-controlled trial

H.Jerome Crampton · Clinical Therapeutics · 2003 · 48 citations

Life Sciences, Immunology, Pharmacology +12

Efficacy and safety of single‐ and multiple‐dose ketotifen fumarate 0.025% ophthalmic solution in a pediatric population

Mark B. Abelson, Nancy J. Ferzola, Cecilia McWhirter et al. · Pediatric Allergy and Immunology · 2004 · 38 citations

Medicine, Pediatrics, Pharmacology +17

A comparison of the relative clinical efficacy of a single dose of ketotifen fumarate 0.025% ophthalmic solution versus placebo in inhibiting the signs and symptoms of allergic rhinoconjunctivitis as induced by the conjunctival allergen challenge model

H.Jerome Crampton · Clinical Therapeutics · 2002 · 27 citations

Life Sciences, Immunology, Pharmacology +12

Efficacy of Once-Daily Olopatadine 0.2% Ophthalmic Solution Compared to Twice-Daily Olopatadine 0.1% Ophthalmic Solution for the Treatment of Ocular Itching Induced by Conjunctival Allergen Challenge

Mark B. Abelson, Dennis L. Spangler, Arthur B. Epstein et al. · Current Eye Research · 2007 · 24 citations

Life Sciences, Pharmacology, Pharmacotherapy +17